A document reveals that redesigned versions of the Apple Watch Ultra 2 and Apple Watch Series 9 are being prepared to resume sales
The Apple Watch sales ban in the U.S. revolved around the use of a blood oximeter patent that allegedly belongs to Masimo. Apple stated that it would issue a software update that would allow it to circumvent the sales ban, though that would require disabling the blood oxygen monitoring feature of the Apple Watch Series 9 and Apple Watch Ultra 2. Now, according to a court document, modified versions of these smartwatches are being prepared to resume sales in the region.Certain Apple Watch models will temporarily have their blood oxygen monitoring software disabled until a final verdict from the court is given
In a document filed with the U.S. Court of Appeals for the Federal Circuit that MacRumors spotted, Masimo states that the latest Apple Watch models were being modified to ensure that they could continue selling in the U.S. Earlier, Masimo said that Apple needed to incorporate hardware modifications to its new Apple Watch models to lift the ban, but it appears that limiting the feature through a software lock will also do the trick.
